| Literature DB >> 24029745 |
Gregory J Keir1, Benjamin Garfield, David M Hansell, Michael R Loebinger, Robert Wilson, Elisabetta A Renzoni, Athol U Wells, Toby M Maher.
Abstract
In sarcoidosis, chronic pulmonary aspergillosis (CPA) may be associated with significant morbidity, and treatment failure rates are often high, even with newer triazole antifungal agents. We report a treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles.Entities:
Keywords: Aspergillus Lung Disease; Sarcoidosis
Mesh：
Substances：
Year: 2013 PMID： 24029745 DOI： 10.1136/thoraxjnl-2013-203988
Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139